ABOUT XINTELA
About the company
History
Management team and Board
Scientific advisors
Business Development
Career
R&D
Technology Platform
Pipeline
Stem cell therapy
Cancer therapy
Indications
Publications
INVESTORS
Share Information
Owner List
PDMR transactions
Financial Calendar
Reports
Analyses
Corporate Governance
General Meetings
Share Issues
Subscribe
IR-contact
Certified Adviser
NEWS & MEDIA
Press Releases
Xintela in the news
Newsletters
Events
Videos
Subscribe
Archive
CONTACT
Svenska
ABOUT XINTELA
About the company
History
Management team and Board
Scientific advisors
Business Development
Career
GDPR Policy
R&D
Technology Platform
Pipeline
Stem cell therapy
Cancer therapy
Indications
Publications
INVESTORS
Share information
Owner list
PDMR transactions
Financial Calendar
Reports
Analyses
Corporate Governance
General Meetings
Share Issues
Subscribe
IR-contact
Certified Adviser
NEWS & MEDIA
Press releases
Xintela in the news
Newsletters
Events
Videos
Subscribe
Press photos/logotypes
Archive
CONTACT
Svenska
SV
Annual General Meeting 2023
Xintela holds its Annual General Meeting on May 12, 2023. Follow the link to read more (in Swedish).
Styrelsens förslag till beslut om införande av ett långsiktigt incitamentsprogram för styrelseledamöter i Xintela (punkt 20)
Styrelsens förslag till beslut om införande av ett långsiktigt incitamentsprogram för anställda m fl i Xintela (punkt 19)
Proxy Form (Swedish)
Fullmaktsformulär
Notice to Annual General Meeting 2023 (Swedish)
Kallelse årsstämma 2023
till Toppen
ABOUT XINTELA
About the company
History
Management team and Board
Scientific advisors
Business Development
Career possibilities
R&D
Technology Platform
Pipeline
Stem cell therapy
Cancer therapy
Indications
Publications
INVESTORS
Share information
Owner list
PDMR transactions
Financial Calendar
Reports
Analyses
Corporate Governance
General Meetings
Share Issues
Subscribe
IR contact
Certified Adviser
NEWS & MEDIA
Press releases
Xintela in the news
Newsletters
Events
Films
Press photographs
Subscribe
Archive
